With increasing life expectancy worldwide, the preservation of functional capacity and vitality in aging populations has become a paramount concern for clinicians and researchers. Ayurveda, an ancient Indian system of medicine, offers a comprehensive and mechanism-based framework for promoting healthy aging and mitigating degenerative changes. This review evaluates the scientific rationale, clinical evidence, and translational implications of Ayurvedic approaches to functional aging and vitality preservation, integrating traditional concepts with modern biomedical perspectives. Emphasis is placed on pathophysiological mechanisms, risk stratification, diagnostic paradigms, and evidence-based interventions relevant to contemporary geriatric practice.
Population aging is reshaping global health priorities, with a significant surge in chronic, degenerative, and functional impairments. Conventional approaches often focus on disease management rather than functional optimization or vitality preservation. Ayurveda conceptualizes aging (Jara) as a natural process influenced by intrinsic constitution (Prakriti), environmental exposures, and behavioral factors, and emphasizes Rasayana (rejuvenative therapies) to preserve vitality (Ojas) and postpone senescence. Recent research highlights the clinical relevance of Ayurvedic interventions including polyherbal formulations, dietary regimens, and lifestyle modifications in supporting functional capacity and quality of life in older adults. This review synthesizes current evidence on Ayurvedic strategies for functional aging, with a focus on clinical applicability and mechanistic insights.
The global elderly population (aged ≥65 years) surpassed 700 million in 2019, with projections exceeding 1.5 billion by 2050. Functional decline, frailty, and multimorbidity contribute to increased healthcare utilization, institutionalization, and mortality. In India and other low- and middle-income countries, traditional medicine particularly Ayurveda remains an integral component of elder care. Epidemiological studies indicate that functional impairments, including sarcopenia, cognitive decline, and reduced resilience, are prevalent in up to 40–60% of elderly cohorts, underscoring the need for preventive and restorative strategies.
Ayurvedic physiology attributes aging to the progressive imbalance of the three Doshas (Vata, Pitta, Kapha), with Vata predominance driving degenerative changes. Modern research aligns this model with neuroendocrine, inflammatory, and oxidative stress pathways implicated in aging. Cellular senescence, mitochondrial dysfunction, and chronic low-grade inflammation (inflammaging) underlie functional decline. Rasayana therapies aim to modulate these processes by enhancing antioxidant defenses, promoting anabolic repair, and maintaining metabolic homeostasis. Herbs such as Withania somnifera (Ashwagandha), Emblica officinalis (Amalaki), and Tinospora cordifolia (Guduchi) exhibit adaptogenic, immunomodulatory, and anti-inflammatory effects, corroborated by preclinical and clinical studies.
Risk stratification in Ayurveda accounts for constitutional susceptibility (Prakriti), age, comorbidities, environmental exposures, and psychosocial determinants. Modern correlates include genetic predispositions, sedentary lifestyle, malnutrition, polypharmacy, and chronic diseases (e.g., diabetes, cardiovascular disorders). Vata-predominant individuals may exhibit accelerated degenerative changes, while Pitta or Kapha types demonstrate unique vulnerability patterns. Identifying modifiable and non-modifiable risk factors guides personalized preventive strategies in clinical practice.
Functional aging manifests as diminished physical strength, cognitive flexibility, endurance, tissue elasticity, and immune competence. Clinically, this is reflected in sarcopenia, osteopenia, cognitive slowing, fatigue, and increased susceptibility to infections. Ayurvedic diagnostics incorporate subjective assessments (e.g., vitality, appetite, sleep quality) and objective measures (e.g., muscle mass, mobility, mental clarity). The multidimensional construct of Ojas is evaluated as a composite marker of vitality, resilience, and disease resistance.
Diagnosis in Ayurveda integrates detailed history, Dosha assessment, Prakriti analysis, and examination of Agni (digestive/metabolic function), Srotas (body channels), and Dhatus (tissues). Contemporary geriatric evaluation utilizes tools such as the Comprehensive Geriatric Assessment (CGA), frailty indices, sarcopenia screening, and cognitive batteries. Recent efforts to harmonize Ayurvedic and biomedical diagnostics have explored the use of biochemical markers (e.g., inflammatory cytokines, oxidative stress indices) in monitoring intervention outcomes.
Ayurvedic management of functional aging revolves around Rasayana therapy, Panchakarma (detoxification), and Dinacharya (daily regimens). Rasayana interventions include polyherbal formulations (e.g., Chyawanprash, Brahma Rasayana), single herbs (Ashwagandha, Amalaki), and medicated ghee (Ghrita). Mechanistically, these agents are shown to enhance mitochondrial function, reduce oxidative damage, and modulate neuroendocrine axes. Dietary recommendations emphasize nutrient density, digestibility, and seasonal adaptation. Lifestyle modifications yoga, meditation, sleep hygiene, and appropriate physical activity are integral to preserving functional capacity. Clinical trials report improvements in muscle strength, cognitive function, immunity, and quality of life with Rasayana and adjunct therapies.
Recent advances include the standardization of Rasayana drugs, elucidation of bioactive phytoconstituents, and integration with modern pharmacology. Controlled studies have demonstrated the efficacy of Ashwagandha in mitigating stress-induced neurodegeneration and improving physical performance in elderly subjects. Nanotechnology-based delivery of herbal actives is being explored to enhance bioavailability and targeted effects. Translational research focuses on molecular mechanisms epigenetic modulation, mitochondrial biogenesis, and autophagy induction underlying the anti-aging effects of Ayurvedic agents. Integration with conventional therapies, such as physiotherapy and cognitive training, is an emerging paradigm in comprehensive geriatric care.
Ayurvedic guidelines recommend early initiation of Rasayana therapy (from middle age), tailored to Prakriti and comorbidities. Regular monitoring of functional status, combined with periodic Panchakarma for detoxification, is advocated. The Ministry of AYUSH (India) and WHO recognize Ayurveda as a complementary approach in geriatric care, emphasizing safety, standardization, and evidence-informed integration. Practitioners are advised to individualize interventions, ensure quality control of herbal products, and monitor for potential herb-drug interactions, especially in polypharmacy settings.
Ayurvedic medicine offers a holistic, mechanism-based approach to the preservation of functional capacity and vitality in aging populations. Current evidence supports the clinical utility of Rasayana therapies, lifestyle modifications, and diet in mitigating age-related decline, with emerging data elucidating their molecular and systemic benefits. Integration of Ayurvedic and biomedical paradigms guided by rigorous research and personalized care holds promise for optimizing healthy aging and enhancing quality of life for elderly patients.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation